Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
- Citation:
- J Clin Oncol vol 34 (14) 1652-1659
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- 753 is parent abstract
- Pharmas:
- AstraZeneca, Bristol-Myers Squibb, Celgene, Oncogenex, Regeneron, Sanofi
- Grants:
- U10CA180821, U10 CA180821, U10 CA180801, U10 CA180858, P30 CA008748, U10 CA180791, U10 CA180828, U10 CA180867, U10 CA180888, U10 CA180819, R01 CA155296
- Corr. Author:
- Authors:
- Susan Halabi William Kevin Kelly Hua Ma Haojin Zhou Nicole C. Solomon Karim Fizazi Catherine M. Tangen Mark Rosenthal Daniel P. Petrylak Maha Hussain Nicholas J. Vogelzang Ian M. Thompson Kim N. Chi Johann de Bono Andrew J. Armstrong Mario A. Eisenberger Abderrahim Fandi Shaoyi Li John C. Araujo Christopher J. Logothetis David I. Quinn Michael J. Morris Celestia S. Higano Ian F. Tannock Eric J. Small
- Networks:
- CA011, CA136, LAPS-CT018, LAPS-IL036, LAPS-NC010, LAPS-NY016, LAPS-OK003, LAPS-TX035, NY021, PCRC
- Study
- CALGB-90601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Bios4, ORIGINAL REPORTS, Urologic Oncology